|
1
|
Drossman DA and Hasler WL: Rome
IV-Functional GI Disorders: Disorders of gut-brain interaction.
Gastroenterology. 150:1257–1261. 2016.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Ericsson CD, Hatz C and DuPont AW:
Postinfectious irritable bowel syndrome. Clin Infect Dis.
46:594–599. 2008.PubMed/NCBI View
Article : Google Scholar
|
|
3
|
Thabane M, Kottachchi DT and Marshall JK:
Systematic review and meta-analysis: The incidence and prognosis of
post-infectious irritable bowel syndrome. Aliment Pharmacol Ther.
26:535–544. 2007.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Thabane M and Marshall JK: Post-infectious
irritable bowel syndrome. World J Gastroenterol. 15:3591–3596.
2009.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Sethi S, Garey KW, Arora V, Ghantoji S,
Rowan P, Smolensky M and DuPont HL: Increased rate of irritable
bowel syndrome and functional gastrointestinal disorders after
Clostridium difficile infection. J Hosp Infect. 77:172–173.
2011.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Stewart GT: Post-dysenteric colitis. BMJ.
1:405–409. 1950.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Kim HS, Kim MS, Ji SW and Park H: The
development of irritable bowel syndrome after Shigella
infection: 3 year follow-up study. Korean J Gastroenterol.
47:300–305. 2006.PubMed/NCBI(In Korean).
|
|
8
|
Ilnyckyj A, Balachandra B, Elliott L,
Choudhri S and Duerksen DR: Post-traveler's diarrhea irritable
bowel syndrome: A prospective study. Am J Gastroenterol.
98:596–599. 2003.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Rodríguez LA and Ruigómez A: Increased
risk of irritable bowel syndrome after bacterial gastroenteritis:
Cohort study. BMJ. 318:565–566. 1999.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Ruigómez A, García Rodríguez LA and Panés
J: Risk of irritable bowel syndrome after an episode of bacterial
gastroenteritis in general practice: Influence of comorbidities.
Clin Gastroenterol Hepatol. 5:465–469. 2007.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Soyturk M, Akpinar H, Gurler O, Pozio E,
Sari I, Akar S, Akarsu M, Birlik M, Onen F and Akkoc N: Irritable
bowel syndrome in persons who acquired trichinellosis. Am J
Gastroenterol. 102:1064–1069. 2007.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Piche T, Vanbiervliet G, Pipau FG, Dainese
R, Hébuterne X, Rampal P and Collins SM: Low risk of irritable
bowel syndrome after Clostridium difficile infection. Can J
Gastroenterol. 21:727–731. 2007.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Marshall JK, Thabane M, Borgaonkar MR and
James C: Postinfectious irritable bowel syndrome after a food-borne
outbreak of acute gastroenteritis attributed to a viral pathogen.
Clin Gastroenterol Hepatol. 5:457–460. 2007.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Marshall JK, Thabane M, Garg AX, Clark WF,
Salvadori M and Collins SM: Walkerton Health Study Investigators.
Incidence and epidemiology of irritable bowel syndrome after a
large waterborne outbreak of bacterial dysentery. Gastroenterology.
131:445–450; quiz 660. 2006.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Wang LH, Fang XC and Pan GZ: Bacillary
dysentery as a causative factor of irritable bowel syndrome and its
pathogenesis. Gut. 53:1096–1101. 2004.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Neal KR, Hebden J and Spiller R:
Prevalence of gastrointestinal symptoms six months after bacterial
gastroenteritis and risk factors for development of the irritable
bowel syndrome: Postal survey of patients. BMJ. 314:779–782.
1997.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Borgaonkar MR, Ford DC, Marshall JK,
Churchill E and Collins SM: The incidence of irritable bowel
syndrome among community subjects with previous acute enteric
infection. Dig Dis Sci. 51:1026–1032. 2006.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Gwee KA, Leong YL, Graham C, McKendrick
MW, Collins SM, Walters SJ, Underwood JE and Read NW: The role of
psychological and biological factors in postinfective gut
dysfunction. Gut. 44:400–406. 1999.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Ji S, Park H, Lee D, Song YK, Choi JP and
Lee SI: Post-infectious irritable bowel syndrome in patients with
Shigella infection. J Gastroenterol Hepatol. 20:381–386.
2005.PubMed/NCBI View Article : Google Scholar
|
|
20
|
McKendrick MW and Read NW: Irritable bowel
syndrome - post Salmonella infection. J Infect. 29:1–3.
1994.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Mearin F, Badía X, Balboa A, Baró E,
Caldwell E, Cucala M, Díaz-Rubio M, Fueyo A, Ponce J, Roset M, et
al: Irritable bowel syndrome prevalence varies enormously depending
on the employed diagnostic criteria: Comparison of Rome II versus
previous criteria in a general population. Scand J Gastroenterol.
36:1155–1161. 2001.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Gwee KA, Graham JC, McKendrick MW, Collins
SM, Marshall JS, Walters SJ and Read NW: Psychometric scores and
persistence of irritable bowel after infectious diarrhoea. Lancet.
347:150–153. 1996.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Tuteja AK, Talley NJ, Gelman SS, Alder SC,
Thompson C, Tolman K and Hale DC: Development of functional
diarrhea, constipation, irritable bowel syndrome, and dyspepsia
during and after traveling outside the USA. Dig Dis Sci.
53:271–276. 2008.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Spence MJ and Moss-Morris R: The cognitive
behavioural model of irritable bowel syndrome: A prospective
investigation of patients with gastroenteritis. Gut. 56:1066–1071.
2007.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Wei X, Chen M and Wang J: The epidemiology
of irritable bowel syndrome and functional constipation of
Guangzhou residents. Zhonghua Nei Ke Za Zhi. 40:517–520.
2001.PubMed/NCBI(In Chinese).
|
|
26
|
Spiller RC: Postinfectious irritable bowel
syndrome. Gastroenterology. 124:1662–1671. 2003.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Moss-Morris R and Spence M: To ‘lump’ or
to ‘split’ the functional somatic syndromes: Can infectious and
emotional risk factors differentiate between the onset of chronic
fatigue syndrome and irritable bowel syndrome? Psychosom Med.
68:463–469. 2006.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Parry SD, Stansfield R, Jelley D, Gregory
W, Phillips E, Barton JR and Welfare MR: Does bacterial
gastroenteritis predispose people to functional gastrointestinal
disorders? A prospective, community-based, case-control study. Am J
Gastroenterol. 98:1970–1975. 2003.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Gupta A and Khanna S: Community-acquired
Clostridium difficile infection: An increasing public health
threat. Infect Drug Resist. 7:63–72. 2014.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Gutiérrez RL, Riddle MS and Porter CK:
Increased risk of functional gastrointestinal sequelae after
Clostridium difficile infection among active duty United
States military personnel (1998-2010). Gastroenterology.
149:1408–1414. 2015.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Walker ARP and Segal I: Epidemiology of
noninfective intestinal diseases in various ethnic groups in South
Africa. Isr J Med Sci. 15:309–313. 1979.PubMed/NCBI
|
|
32
|
Buéno L, Fioramonti J and Garcia-Villar R:
Pathobiology of visceral pain: molecular mechanisms and therapeutic
implications. III. Visceral afferent pathways: a source of new
therapeutic targets for abdominal pain. Am J Physiol Gastrointest
Liver Physiol. 278:G670–G676. 2000.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Neal KR, Barker L and Spiller RC:
Prognosis in post-infective irritable bowel syndrome: A six year
follow up study. Gut. 51:410–413. 2002.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Rohde CL, Bartolini V and Jones N: The use
of probiotics in the prevention and treatment of
antibiotic-associated diarrhea with special interest in
Clostridium difficile-associated diarrhea. Nutr Clin Pract.
24:33–40. 2009.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Shukla G, Devi P and Sehgal R: Effect of
Lactobacillus casei as a probiotic on modulation of
giardiasis. Dig Dis Sci. 53:2671–2679. 2008.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Resta-Lenert S and Barrett KE: Live
probiotics protect intestinal epithelial cells from the effects of
infection with enteroinvasive Escherichia coli (EIEC). Gut.
52:988–997. 2003.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Drossman DA and Dumitrascu DL: Rome III:
New standard for functional gastrointestinal disorders. J
Gastrointestin Liver Dis. 15:237–241. 2006.PubMed/NCBI
|
|
38
|
Lewis SJ and Heaton KW: Stool form scale
as a useful guide to intestinal transit time. Scand J
Gastroenterol. 32:920–924. 1997.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Klem F, Wadhwa A, Prokop LJ, Sundt WJ,
Farrugia G, Camilleri M, Singh S and Grover M: Prevalence, risk
factors, and outcomes of irritable bowel syndrome after infectious
enteritis: A systematic review and meta-analysis. Gastroenterology.
152:1042–1054.e1. 2017.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Litleskare S, Rortveit G, Eide GE, Hanevik
K, Langeland N and Wensaas KA: Prevalence of irritable bowel
syndrome and chronic fatigue 10 years after Giardia
infection. Clin Gastroenterol Hepatol. 16:1064–1072.e4.
2018.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Mearin F, Pérez-Oliveras M, Perelló A,
Vinyet J, Ibañez A, Coderch J and Perona M: Dyspepsia and irritable
bowel syndrome after a Salmonella gastroenteritis outbreak:
One-year follow-up cohort study. Gastroenterology. 129:98–104.
2005.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Wadhwa A, Al Nahhas MF, Dierkhising RA,
Patel R, Kashyap P, Pardi DS, Khanna S and Grover M: High risk of
post-infectious irritable bowel syndrome in patients with
Clostridium difficile infection. Aliment Pharmacol Ther.
44:576–582. 2016.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Peterson LR, O'Grady S, Keegan M, Fisher
A, Zelencik S, Kufner B, Shah M, Lim R, Schora D, Das S, et al:
Reduced Clostridioides difficile infection in a pragmatic
stepped-wedge initiative using admission surveillance to detect
colonization. PLoS One. 15(e0230475)2020.PubMed/NCBI View Article : Google Scholar
|
